Nature Reviews Clinical Oncology (2020) https://doi.org/10.1038/s41571-020-0382-2 Published online 08 June 2020
The originally published article contained an error in Table 1, in which oleclumab was incorrectly described as an anti-CD79 monoclonal antibody (mAb) instead of an anti-CD73 mAb. This editorial error has been corrected in the HTML and PDF versions of the manuscript to reflect that oleclumab in an anti-CD73 mAb.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allard, B., Allard, D., Buisseret, L. et al. Publisher Correction: The adenosine pathway in immuno-oncology. Nat Rev Clin Oncol 17, 650 (2020). https://doi.org/10.1038/s41571-020-0415-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-020-0415-x
This article is cited by
-
Norepinephrine inhibits CD8+ T-cell infiltration and function, inducing anti-PD-1 mAb resistance in lung adenocarcinoma
British Journal of Cancer (2023)
-
P2X7 is a cytotoxic receptor….maybe not: implications for cancer
Purinergic Signalling (2021)
